Table Of Contents:
1. Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
2. Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
3. Compounding Pearls -- Wound Care: Burn Healing, Part 2
4. Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
5. Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
6. Quality Control: Rapid Sterility Testing for Compounding Pharmacies
7. Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
8. Calculations
9. Benzonatate 50 mg/mL in Ora-Sweet
10. Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
11. Doxepin Hydrochloride 5% in Cetaphil Cream
12. Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
13. Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
14. Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
15. Lisinopril 1 mg/mL in SyrSpend SF pH4
16. Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
17. Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
18. Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4
19. Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
20. Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
21. Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
22. Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review